BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

21 hedge funds and large institutions have $4.52M invested in ProShares Ultra NASDAQ Biotechnology in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
4
Closed
7
Calls
$1.3M
Puts
$1.48M
Net Calls
-$184K
Net Calls Change
-$1.57M

Top Buyers

1
TFA
1
Toth Financial Advisory
Virginia
$1.5M
2
WWM
2
Westwood Wealth Management
California
$575K
3
TCBWMS
3
Texas Capital Bank Wealth Management Services
Texas
$288K
4
UBS Group
4
UBS Group
Switzerland
$13.7K
5
S
5
SignatureFD
Georgia
$8.63K

Top Sellers

1
IMC Chicago
1
IMC Chicago
Illinois
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
CCP
4
Clarity Capital Partners
California
$0
5
Simplex Trading
5
Simplex Trading
Illinois
$30K
Name Holding Trade Value Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
– -$6K -100 Closed
FGAM
27
Financial Gravity Asset Management
Texas
– -$348 -8 Closed
Fidelity Investments
28
Fidelity Investments
Massachusetts
– -$57 -1 Closed
1
2